HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 625-636 of 4,505
Drug study icon
CompletedNCT03983018

Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)

Official study title

Rituximab - Immunotherapy for Schizophrenia Spectrum Disorder in Adults: An Open Pilot Study

This study has finished and is no longer accepting participants.

In Örebro
SchizophreniaMedication studyAges 18–40
Countries
Sweden
Sponsor
Region Örebro County
Behavioral study icon
WithdrawnNCT05389345

tDCS and Executive Function Training for Schizophrenia

Official study title

Effects of Adding Transcranial Direct Current Stimulation to Executive Function Training for Schizophrenia-spectrum Disorders - a Randomized Control Trial

This study was withdrawn before enrollment.

In Whitby
SchizophreniaBehavioural studyAges 18–65
Countries
Canada
Sponsor
University of Toronto
Drug study icon
CompletedEUCTR 2005-002304-41

Early versus late initiation of treatment with Risperdal Consta in subjects with schizophrenia or schizoaffective disorder after an acute episode

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark
SchizophreniaHistorical research record
Countries
United Kingdom, Denmark, Finland, + 3 others
Sponsor
Janssen-Cilag EMEA Medical Affairs
Drug study icon
Recruitment unclearEUCTR 2021-001337-40

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE EFFICACY AND SAFETY OF BXCL501 IN AGITATION ASSOCIATED WITH PEDIATRIC SCHIZOPHRENIA AND Bipolarity

Official study title

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE EFFICACY AND SAFETY OF BXCL501 IN AGITATION ASSOCIATED WITH PEDIATRIC SCHIZOPHRENIA AND BIPOLAR DISORDER

Original registry wording; source language not specified.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
Schizophrenia, BipolarityHistorical research record
Countries
Spain
Sponsor
BioXcel Therapeutics, Inc.
Drug study icon
Recruitment unclearEUCTR 2014-003008-53

Clonidine Augmentation Therapy in Schizophrenia

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Netherlands
SchizophreniaHistorical research record
Countries
Netherlands
Sponsor
University Medical Center Utrecht
Drug study icon
Not recruitingEUCTR 2020-004752-16

PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF RO6889450 (RALMITARONT) IN PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER AND NEGATIVE SYMPTOMS

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
SchizophreniaHistorical research record
Countries
Bulgaria, Croatia, Poland, + 1 other
Sponsor
F. Hoffmann-La Roche Ltd
Drug study icon
CompletedNCT00222794

A study to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in people with Schizophrenia

Official study title

A Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder

This study has finished and is no longer accepting participants.

In Pittsburgh
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
University of Pittsburgh

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.